Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas
University of Alabama at Birmingham
University of Alabama at Birmingham
M.D. Anderson Cancer Center
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Gustave Roussy, Cancer Campus, Grand Paris
Institut Bergonié
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Situs Cancer Research Center
Sarcoma Oncology Research Center, LLC
ImmunityBio, Inc.
ImmunityBio, Inc.
Children's National Research Institute
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Brown University
Wake Forest University Health Sciences
University of California, Davis
Boehringer Ingelheim
The Cooper Health System
OHSU Knight Cancer Institute
Pfizer
Ohio State University Comprehensive Cancer Center
Translational Research in Oncology
Eastern Cooperative Oncology Group
Mayo Clinic
University of Iowa
University of Iowa
Peking University People's Hospital
Emory University
Albert Einstein College of Medicine
University of Wisconsin, Madison
Presage Biosciences
Organon and Co
M.D. Anderson Cancer Center
Agenus Inc.
Deciphera Pharmaceuticals, LLC
National Institutes of Health Clinical Center (CC)
Brown University
Australia New Zealand Gynaecological Oncology Group
Brown University
Boston Scientific Corporation
Abramson Cancer Center at Penn Medicine
NKGen Biotech, Inc.
Jonsson Comprehensive Cancer Center
Italian Sarcoma Group
Columbia University
Dana-Farber Cancer Institute
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
OHSU Knight Cancer Institute
Peking University People's Hospital